Cases & Deals

Celgene develops global patent portfolio for small molecule therapeutics

Clients Celgene Corporation, a Bristol-Myers Squibb company

Jones Day represents Celgene Corporation (now a Bristol-Myers Squibb company) in the establishment of a global patent portfolio related to small molecules for the treatment of cancer and autoimmune disorders.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.